Skip to main content

Table 5 Combination of PET/MRI features as well as the ADC allows differentiation between chemotherapy responders and non-responders with high sensitivity and specificity

From: [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

  Cut-off value ROC-AUC Sensitivity Specificity
∆TLG 50%
*∆ADC max
0 0.86 0.92 0.8
∆SUVmax
*∆MTV50%
0 1.00 1.00 1.00
∆SUVmax
*∆TLG 50%
0 0.86 0.92 0.80
∆MTV50%
*∆ADC max
0.10 1.00 1.00 1.00